Try our Advanced Search for more refined results

Securities and Exchange Commission v. CR Intrinsic Investors, L.L.C. et al

  1. March 05, 2026

    Pfizer Gets OK For $29M SEC Payout From Insider Case

    A New York federal judge on Thursday approved a request from the U.S. Securities and Exchange Commission and Pfizer to have $29 million paid out to a Pfizer subsidiary from the roughly $75.2 million distribution left over from a $602 million insider trading deal.

  2. February 11, 2026

    Pfizer, SEC Reach $29M Deal In Insider Trading Fund Dispute

    Pfizer and the U.S. Securities and Exchange Commission have jointly asked a New York federal judge to allow $29 million out of the roughly $75.2 million distribution leftover from a $602 million insider trading deal to be paid out to a Pfizer subsidiary.

  3. November 19, 2024

    Pfizer Unit Can't Get $75M Left In Insider Trading Deal Fund

    A New York federal judge Tuesday agreed with the U.S. Securities and Exchange Commission that roughly $75.2 million leftover in settlement funds should be transferred to the U.S. Treasury — not a Pfizer subsidiary — now that distribution of the $602 million insider trading deal has concluded.

  4. January 26, 2015

    SAC Victims' Fund OK'd In $602M Insider Trading Deal

    The U.S. Securities and Exchange Commission got the go-ahead to set up a fund to distribute a $602 million insider trading settlement to victims of SAC Capital Advisors LP's alleged scheme, after Pfizer Inc. agreed to drop its objection, according to a Monday order in New York federal court.

  5. December 18, 2014

    SAC Won't Oppose Victims Fund For $602M Settlement

    SAC Capital Advisors LP has told a New York federal judge it doesn't object to the U.S. Securities and Exchange Commission setting up a fair fund to distribute a $602 million insider trading settlement to victims of the alleged scheme, according to a court filing made public Thursday.

  6. November 14, 2014

    SEC Wants $602M SAC Settlement To Go To Victims

    The U.S. Securities and Exchange Commission asked a New York federal court on Friday to set up a "fair fund" that would allow the $602 million paid by SAC Capital Advisors LP in connection with alleged insider trading of Elan Corp. and Wyeth LLC stock to be used to compensate investors who were harmed.

  7. October 09, 2014

    SEC Weighs Victims' Fund From $602M SAC Settlement

    The U.S. Securities and Exchange Commission said Thursday that it is considering establishing a fund from the $602 million settlement of insider trading allegations reached with SAC Capital Advisors LP to satisfy claims by investors who say they were harmed by the fraud.

  8. June 18, 2014

    Judge Reluctantly OKs SAC's $600M 'No Admit, No Deny' Deal

    A New York federal judge on Wednesday somewhat reluctantly gave final approval for the U.S. Securities and Exchange Commission's $600 million "no admit, no deny" insider trading settlements with affiliates of CR Intrinsic Investors LLC and SAC Capital Advisors LP, in light of the Second Circuit's recent ruling in a case against Citigroup Inc.

  9. June 16, 2014

    SEC Wants 'No Admit, No Deny' Pact With SAC Approved

    The U.S. Securities and Exchange Commission on Monday asked a New York federal judge to approve its $600 million "no admit, no deny" insider trading settlement with affiliates of SAC Capital Advisors LP, citing the Second Circuit's recent ruling in a case against Citigroup Inc.

  10. November 15, 2013

    Prosecutors Can't Stay Civil Suit Against SAC Exec

    A New York federal judge on Friday rejected the government's request to halt discovery in the civil suit against former SAC Capital Advisors LP manager Mathew Martoma pending the resolution of Martoma's criminal trial, saying prosecutors had failed to show they would suffer prejudice without a stay.